Analyst Activity – Leerink Swann Raises Its Price Target On ABIOMED (NASDAQ:ABMD) to

Analyst Ratings For ABIOMED (NASDAQ:ABMD)

Story continues below

Today, Leerink Swann raised its price target on ABIOMED (NASDAQ:ABMD) to per share.

Some recent analyst ratings include

  • 1/4/2018-Piper Jaffray Companies Reiterated Rating of Buy.
  • 11/1/2017-SunTrust Banks Reiterated Rating of Buy.
  • 10/29/2017-BTIG Research Reiterated Rating of Hold.
  • 7/10/2017-Morgan Stanley Reiterated Rating of Equal Weight.
  • 6/8/2017-William Blair Reiterated Rating of Outperform .

Recent Insider Trading Activity For ABIOMED (NASDAQ:ABMD)
ABIOMED (NASDAQ:ABMD) has insider ownership of 7.00% and institutional ownership of 90.75%.

  • On 10/30/2017 Dorothy E Puhy, Director, sold 6,364 with an average share price of $179.08 per share and the total transaction amounting to $1,139,665.12.
  • On 10/30/2017 Michael G Howley, VP, sold 10,000 with an average share price of $178.64 per share and the total transaction amounting to $1,786,400.00.
  • On 10/2/2017 Andrew J Greenfield, VP, sold 11,282 with an average share price of $169.32 per share and the total transaction amounting to $1,910,268.24.
  • On 8/30/2017 Eric A Md Rose, Director, sold 982 with an average share price of $145.17 per share and the total transaction amounting to $142,556.94.
  • On 8/24/2017 Eric A Md Rose, Director, sold 23,018 with an average share price of $151.09 per share and the total transaction amounting to $3,477,789.62.
  • On 8/15/2017 Paul Thomas, Director, sold 10,000 with an average share price of $154.71 per share and the total transaction amounting to $1,547,100.00.
  • On 7/31/2017 David M Weber, COO, sold 16,500 with an average share price of $147.63 per share and the total transaction amounting to $2,435,895.00.

Recent Trading Activity for ABIOMED (NASDAQ:ABMD)
Shares of ABIOMED closed the previous trading session at 227.86 up +1.97 0.87% with 226.08999633789062 shares trading hands.

An ad to help with our costs